CDK7-IN-12
Modify Date: 2025-08-25 15:39:16
CDK7-IN-12 structure
|
Common Name | CDK7-IN-12 | ||
|---|---|---|---|---|
| CAS Number | 2750638-94-7 | Molecular Weight | 400.40 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H19F3N6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CDK7-IN-12CDK7-IN-12 is a potent inhibitor of CDK7. CDK7-IN-12 plays a key role in transcriptional regulation and cell cycle regulation. CDK7-IN-12 effectively inhibit malignant tumor proliferation in vitro and in vivo. CDK7-IN-12 has the potential for the research of cancer disease (extracted from patent WO2021249417A1, compound 43)[1]. |
| Name | CDK7-IN-12 |
|---|
| Description | CDK7-IN-12 is a potent inhibitor of CDK7. CDK7-IN-12 plays a key role in transcriptional regulation and cell cycle regulation. CDK7-IN-12 effectively inhibit malignant tumor proliferation in vitro and in vivo. CDK7-IN-12 has the potential for the research of cancer disease (extracted from patent WO2021249417A1, compound 43)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Jing Wang, et al. Heterocyclic compounds and their derivatives. Patent WO2021249417A1. |
| Molecular Formula | C20H19F3N6 |
|---|---|
| Molecular Weight | 400.40 |